The invention is directed to the use of imatinib mesylate for treating polycythemia vera. Imatinib mesylate is surprisingly effective at controlling the symptoms of polycythemia vera and reducing the need for phlebotomy.

 
Web www.patentalert.com

< Nucleoside derivatives for treating hepatitis C virus infection

< Fusion proteins of mycobacterium tuberculosis

> TEM sample equipped with an identifying function, focused ion beam device for processing TEM sample, and transmission electron microscope

> Electronic writing and erasing pencil
~ 00285